178196 Sigma-Aldrichα₁-Antichymotrypsin, Human Plasma - CAS 141176-92-3 - Calbiochem
Acute-phase protein present at ~45 mg/100 ml in plasma.
More>> Acute-phase protein present at ~45 mg/100 ml in plasma. Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: α₁-Achy, α₁-1X, α₁-1X-Glycoprotein
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # |
|---|
| 141176-92-3 |
Products
| 产品目录编号 | 包装 | 数量 / 包装 | |
|---|---|---|---|
| 178196-100UGCN | 塑胶安瓿;塑胶针药瓶 | 100 μg | |
| 178196-1MGCN | 塑胶安瓿;塑胶针药瓶 | 1 mg |
| References | |
|---|---|
| References | Desrochers, P.E., et al. 1992. J. Biol. Chem. 267, 5005. Rayford, A., et al. 1992. J. Neurochem. 58, 88. Travis, J., et al. 1978. Biochemistry 17, 5651. |
| Product Information | |
|---|---|
| CAS number | 141176-92-3 |
| Activity | ≥85% inhibition of cathepsin G when assayed at 25°C, pH 7.4, using Suc-Ala-Ala-Pro-Phe-pNA as substrate. |
| ATP Competitive | N |
| Form | Solid |
| Formulation | Lyophilized from 150 mM NaCl, 20 mM Tris-HCl, pH 7.4. |
| Reversible | N |
| Quality Level | MQ100 |
| Applications |
|---|
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 178196-100UGCN | 04055977223071 |
| 178196-1MGCN | 04055977223064 |
Documentation
α₁-Antichymotrypsin, Human Plasma - CAS 141176-92-3 - Calbiochem MSDS
| 职位 |
|---|
α₁-Antichymotrypsin, Human Plasma - CAS 141176-92-3 - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 178196 |
参考
| 参考信息概述 |
|---|
| Desrochers, P.E., et al. 1992. J. Biol. Chem. 267, 5005. Rayford, A., et al. 1992. J. Neurochem. 58, 88. Travis, J., et al. 1978. Biochemistry 17, 5651. |



